These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

668 related articles for article (PubMed ID: 33563317)

  • 1. Prospective pathway signaling and prognostic values of MicroRNA-9 in ovarian cancer based on gene expression omnibus (GEO): a bioinformatics analysis.
    Zuo L; Li X; Tan Y; Zhu H; Xiao M
    J Ovarian Res; 2021 Feb; 14(1):29. PubMed ID: 33563317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
    Li Y; Li L
    J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatics analysis of prognostic value and prospective pathway signal of miR-30a in ovarian cancer.
    Lu W; Wu Y; Lu CX; Zhu T; Ren ZL; Yu Z
    J Ovarian Res; 2020 Oct; 13(1):120. PubMed ID: 33004058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatics analysis of mRNA and miRNA microarray to identify the key miRNA-mRNA pairs in cisplatin-resistant ovarian cancer.
    Xue B; Li S; Jin X; Liu L
    BMC Cancer; 2021 Apr; 21(1):452. PubMed ID: 33892654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and analysis of genes associated with epithelial ovarian cancer by integrated bioinformatics methods.
    Gui T; Yao C; Jia B; Shen K
    PLoS One; 2021; 16(6):e0253136. PubMed ID: 34143800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of novel mRNA-miRNA-lncRNA regulatory networks associated with prognosis of ovarian cancer.
    Gao L; Li X; Nie X; Guo Q; Liu Q; Qi Y; Liu J; Lin B
    J Cancer; 2020; 11(23):7057-7072. PubMed ID: 33123295
    [No Abstract]   [Full Text] [Related]  

  • 8. Bioinformatics Analysis Identifies the Estrogen Receptor 1 (ESR1) Gene and hsa-miR-26a-5p as Potential Prognostic Biomarkers in Patients with Intrahepatic Cholangiocarcinoma.
    Qin X; Song Y
    Med Sci Monit; 2020 May; 26():e921815. PubMed ID: 32435051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of significant genes with poor prognosis in ovarian cancer via bioinformatical analysis.
    Feng H; Gu ZY; Li Q; Liu QH; Yang XY; Zhang JJ
    J Ovarian Res; 2019 Apr; 12(1):35. PubMed ID: 31010415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments.
    Zheng MJ; Li X; Hu YX; Dong H; Gou R; Nie X; Liu Q; Ying-Ying H; Liu JJ; Lin B
    J Cell Physiol; 2019 Jul; 234(7):11023-11036. PubMed ID: 30633343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated miRNA-mRNA Expression Profiles Revealing Key Molecules in Ovarian Cancer Based on Bioinformatics Analysis.
    Li C; Hong Z; Ou M; Zhu X; Zhang L; Yang X
    Biomed Res Int; 2021; 2021():6673655. PubMed ID: 34734085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of key miRNAs and their targets in peripheral blood mononuclear cells of IgA nephropathy using bioinformatics analysis.
    Liu L; Yang Y; Yu D
    Medicine (Baltimore); 2021 Jul; 100(26):e26495. PubMed ID: 34190177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of key biomarkers associated with development and prognosis in patients with ovarian carcinoma: evidence from bioinformatic analysis.
    Shen J; Yu S; Sun X; Yin M; Fei J; Zhou J
    J Ovarian Res; 2019 Nov; 12(1):110. PubMed ID: 31729978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three hematologic/immune system-specific expressed genes are considered as the potential biomarkers for the diagnosis of early rheumatoid arthritis through bioinformatics analysis.
    Cheng Q; Chen X; Wu H; Du Y
    J Transl Med; 2021 Jan; 19(1):18. PubMed ID: 33407587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microarray data analysis on gene and miRNA expression to identify biomarkers in non-small cell lung cancer.
    Jin X; Guan Y; Zhang Z; Wang H
    BMC Cancer; 2020 Apr; 20(1):329. PubMed ID: 32299382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioinformatics analysis to determine the prognostic value and prospective pathway signaling of miR-126 in non-small cell lung cancer.
    Jiao Z; Yu A; He X; Xuan Y; Zhang H; Wang G; Shi M; Wang T
    Ann Transl Med; 2020 Dec; 8(24):1639. PubMed ID: 33490151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Data Mining of Differentially Expressed Genes in Ovarian Epithelial Carcinoma: Implications in Precise Medicine.
    Zhao J; Gao H; He Y
    Curr Top Med Chem; 2021 Oct; 21(14):1285-1300. PubMed ID: 34238161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of candidate biomarkers and analysis of prognostic values in ovarian cancer by integrated bioinformatics analysis.
    Xu Z; Zhou Y; Cao Y; Dinh TL; Wan J; Zhao M
    Med Oncol; 2016 Nov; 33(11):130. PubMed ID: 27757782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of latent biomarkers in connection with progression and prognosis in oral cancer by comprehensive bioinformatics analysis.
    Reyimu A; Chen Y; Song X; Zhou W; Dai J; Jiang F
    World J Surg Oncol; 2021 Aug; 19(1):240. PubMed ID: 34384424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis.
    Li T; Gao X; Han L; Yu J; Li H
    World J Surg Oncol; 2018 Jun; 16(1):114. PubMed ID: 29921304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.